Literature DB >> 8758208

The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.

P Ramani1, J K Cowell.   

Abstract

WT1, the Wilms' tumour suppressor gene located at chromosome 11p13, plays an important role in the development of the kidney. It is mutated in 10 per cent of Wilms' tumours (WTs) and their putative precursors called nephrogenic rests (NRs). A sensitive immunohistochemical technique was established to localize the WT1 gene product in archival normal tissues and paediatric renal tumour samples. Strong nuclear signal was seen in the various sites such as the kidneys, gonads, and decidua. Nuclear immunoreactivity of variable intensity was also seen in the skeletal muscle, smooth muscle of urinary bladder, ureter, and arteries. All 28 WTs (including the anaplastic variant) showed the WT1 gene product in a varying proportion of the blastema, epithelium, and stroma. The anaplastic nuclei in six WTs showed an intensity of staining comparable to their adjacent favourable histology counterparts. All the intralobar and perilobar types of NR demonstrated the WT1 gene product. All three malignant rhabdoid tumours were positive, while three of four mesoblastic nephromas and a clear cell sarcoma were negative. These findings provide an insight into the interrelationships of these renal tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8758208     DOI: 10.1002/(SICI)1096-9896(199606)179:2<162::AID-PATH545>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study.

Authors:  A K Charles; S Mall; J Watson; P J Berry
Journal:  Mol Pathol       Date:  1997-06

Review 2.  WT1 Alternative Splicing: Role of Its Isoforms in Neuroblastoma.

Authors:  Daniela Maria Rasà; Agata Grazia D'Amico; Grazia Maugeri; Sebastiano Cavallaro; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2017-05-22       Impact factor: 3.444

Review 3.  Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers?

Authors:  Uta Erdbrügger; Thu H Le
Journal:  J Am Soc Nephrol       Date:  2015-08-06       Impact factor: 10.121

4.  Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma.

Authors:  Stephanie N Kinney; John N Eble; Ondrej Hes; Sean R Williamson; David J Grignon; Mingsheng Wang; Shaobo Zhang; Lee Ann Baldrige; Guido Martignoni; Matteo Brunelli; Lisha Wang; Eva Comperat; Rong Fan; Rodolfo Montironi; Gregory T MacLennan; Liang Cheng
Journal:  Mod Pathol       Date:  2015-08-07       Impact factor: 7.842

5.  Cell cycle regulation and differentiation in the human podocyte lineage.

Authors:  M Nagata; K Nakayama; Y Terada; S Hoshi; T Watanabe
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

6.  WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.

Authors:  Y Yang; C Jeanpierre; G R Dressler; M Lacoste; P Niaudet; M C Gubler
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

7.  Desmoplastic small round cell tumour of childhood: a report of four cases demonstrating wider clinical features and variable outcome.

Authors:  R Ray; H C Traunecker; F Raafat; M C Stevens
Journal:  Sarcoma       Date:  1997

8.  WT1 expression in the human fetus during development.

Authors:  R Ambu; L Vinci; C Gerosa; D Fanni; E Obinu; A Faa; V Fanos
Journal:  Eur J Histochem       Date:  2015-06-29       Impact factor: 3.188

Review 9.  Reassessing target antigens for adoptive T-cell therapy.

Authors:  Christian S Hinrichs; Nicholas P Restifo
Journal:  Nat Biotechnol       Date:  2013-10-20       Impact factor: 54.908

10.  Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.

Authors:  Benjamin Uttenthal; Irma Martinez-Davila; Adam Ivey; Charles Craddock; Frederick Chen; Andras Virchis; Panagiotis Kottaridis; David Grimwade; Asim Khwaja; Hans Stauss; Emma C Morris
Journal:  Br J Haematol       Date:  2013-11-16       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.